Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • STX vs GSK✓SelectedUSD · GSKSTX vs GSK performance historyLatest closeAs of-3.09%11/13
Stock and ETF performance explorer

STX vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+673.8%
GSK return
+65.8%
Excess return
+608.0%
Maximum drawdown
-57.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.1%+0.5%-3.6%-3.1%
7D+14.6%+1.1%+13.5%+14.7%
30D-26.0%+6.3%-32.3%-25.7%
3M-42.6%+1.8%-44.4%-42.4%
6M-35.3%+1.7%-36.9%-35.4%
YTD+92.5%+6.5%+85.9%+90.1%
1Y+102.4%+9.5%+92.9%+98.9%
3Y+673.8%+65.3%+608.5%+661.6%
All+673.8%+65.8%+608.0%+661.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling